---
title: "OBiO Tech released its 2024 annual performance, with a net loss attributable to the parent company of 322 million yuan, an expanded loss"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236447765.md"
description: "According to the Zhitong Finance APP, OBiO Tech released its 2024 annual report, stating that the company's operating revenue for 2024 is CNY 248 million, a year-on-year increase of 21.16%; the net loss attributable to shareholders of the listed company is CNY 322 million, with losses widening; the net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, is CNY 336 million, with losses widening; the basic loss per share is CNY 0.497"
datetime: "2025-04-17T13:58:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236447765.md)
  - [en](https://longbridge.com/en/news/236447765.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236447765.md)
generator: "portal-rs"
---

# OBiO Tech released its 2024 annual performance, with a net loss attributable to the parent company of 322 million yuan, an expanded loss

According to the Zhitong Finance APP, OBiO Tech (688238.SH) released its annual report for 2024, reporting an operating income of 248 million yuan for the year 2024, a year-on-year increase of 21.16%; a net loss attributable to shareholders of the listed company of 322 million yuan, with losses widening; a net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses of 336 million yuan, with losses widening; and a basic loss per share of 0.497 yuan/share

### Related Stocks

- [688238.CN](https://longbridge.com/en/quote/688238.CN.md)

## Related News & Research

- [China Resources Pharma unit KPC wins registration to issue RMB 1 billion in medium-term notes](https://longbridge.com/en/news/297630970.md)
- [Hollywood summer box office hits pre-pandemic stride as women, younger audiences return to theaters](https://longbridge.com/en/news/298021676.md)
- [Khan demands Burnham block Heathrow expansion over net zero](https://longbridge.com/en/news/297836820.md)
- [Galway Metals (CVE:GWM) Director Robert Hinchcliffe Purchases 15,000 Shares](https://longbridge.com/en/news/297688666.md)
- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**